IAS News and Literature Updates:
April-May 2017
 From the President's Desk:
Yuji Matsuzawa


The IAS continues to support early career scientists interested in research that will then benefit their home countries, laboratories, clinics, and ultimately our patients through the IAS Visiting Fellowship Award program. 

The objectives of the Visiting Fellowship are to:

  • Improve skills and knowledge in the field of cardiovascular disease
  • Learn new research techniques in the field of cardiovascular disease
  • Implement new techniques or initiate new programs in atherosclerosis and cardiovascular disease in the home country

This year the application call for the IAS Visiting Fellowship Award which is open to scientists ≤40 years old working in the field of atherosclerosis and related diseases, not only generated applications from many different countries globally but the winners from Brazil, China, Spain, and Switzerland will also be able to gain worldwide experience—in Canada, the Netherlands, and the United States. The competition this year was very stiff and as such, we would like to also thank the IAS Award Review Committee for its difficult and challenging job in evaluating the many interesting and eligible submissions.
 
> Complete Article <

APPLY NOW!!

IAS Visiting Fellowship Opportunities
Application Deadline: January 31, 2018
3 - Month Visiting Fellowship Award $5,000
• 6 - Month Visiting Fellowship Award $8,000
 

For the Flyer Click Here
For more information Click Here

        A SECOND FH LIPID CLINIC OPENS IN IRAQ        

IAS is pleased to inform our readers that a second Lipid Clinic opened recently in Iraq thanks to the impressive efforts of Dr Mutaz Al-Sabah. This represents another success story deriving from the educational activities of the IAS and OSLA in the MENA Region. We would love to hear from our member societies about other such exciting and important successes in the field throughout the world and look forward to hearing from you.​
Please link to the photos of the Opening
Also included in this Newsletter:

Toronto, Canada
June 9 - 12, 2018


XVIII International Symposium on Atherosclerosis

In the News: 
 
FEATURED COMMENTARIES: 

CXCL4-induced Macrophages in Human Atherosclerosis

By: Christian A. Gleißner


Atherosclerosis is considered an inflammatory disease of the arterial wall triggered by the immune response to lipids retained in the subendothelial space. Monocytes and monocyte-derived cells (most often termed macrophages) play an essential role in this process. By taking up unmodified and modified (mostly oxidized) low density lipoprotein (LDL) particles, macrophages promote an inflammatory environment through secretion of chemokines and cytokines leading to recruitment of further immune cells and vascular smooth muscle cells.


View Complete Commentary <

Abdominal Adiposopathy and Atherosclerosis
By: Leonardo Roever and Carl J Lavie


Obesity has been increasing in epidemic proportions in the United States (US) and most of the westernized world, and recent statistics in the US indicate a prevalence of obesity, defined by body mass index (BMI) ≥ 30 kg/m2, at 38% and morbid, or Class III obesity (BMI ≥ 40 kg /m2), at almost 8% of the adult population. All obesity is not created equally, however, and abdominal adiposopathy drives the progression of multiple risk factors for atherosclerosis regardless of BMI, and is a metabolic syndrome (MetS) correlate with atherosclerosis, in part due to insulin resistance (IR) and various other cardiovascular (CV) disease (CVD) factors.

> View Complete Commentary <

UPCOMING MEETINGS:


June 10, 2017

Chilean Working Group on Atherosclerosis Course: Advances in the Treatment of Hypertension and Dyslipidemia
Santiago, Chile

Email: rodrigoalonsok@gmail.com


June 8-10, 2017

12th Metabolic Syndrome, Type II Diabetes, and Atherosclerosis Congress (MSDA 2017)
St. Petersburg, Russia



View Meeting Website


June 10, 2017

Chilean Working Group on Atherosclerosis Course: Advances in the Treatment of Hypertension and Dyslipidemia
Antofagasta, Chile

Email: rodrigoalonsok@gmail.com


July 13-14, 2017

Chilean Working Group on Atherosclerosis 2nd Course: Update on Cardiovascular Risk Factors: From Theory to Clinical Practice
Santiago, Chile




Email: rodrigoalonsok@gmail.com


February 27 - March 1, 2018

Philippine Lipid and Atherosclerosis Society 
11th APSAVD Congress Annual Scientific Meeting on Addressing Regional Diversity in Atherosclerosis and Vascular Disease in the Asia-Pacific Region
Iloilo City, Philippines


View Meeting Website



For a complete listing of all Member Society meetings and educational activities


Please Click Here

Acknowledgements

The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission: Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, Ono Pharmaceutical Co., Ltd., OSLA - Oman Society of Lipids and Atherosclerosis, Otsuka Pharmaceutical Co., Ltd., Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College.

>> Back To Top <<
 
IAS Newsletter Editors
&
Website Editorial Board
 
Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta, PhD
Milan, Italy
Emanuela Folco, PhD
Milan, Italy
Ann Jackson, MBA
Houston, TX, USA

Website & Newsletter Editors
Elena Colombo
Milan, Italy
Yelonda Williams, BA
Dallas, TX, USA

************************************************************************************************************************************************************

You are a valued member of the International Atherosclerosis Society. You are receiving this email because you opted in at our website - www.athero.org

Unsubscribe <<Email Address>> from this list.

Our mailing address is:
International Atherosclerosis Society
Fondazione Giovanni Lorenzini Medical Science Foundation
viale Piave 35
Milan, Italy 20129
Italy

Add us to your address book

Copyright (C) 2017 International Atherosclerosis Society All rights reserved.

Forward this email to a friend
Update your profile